CPP initiates NCI-funded Phase II trial of CPP-1X for gastric cancer
US-based Cancer Prevention Pharmaceuticals (CPP) has initiated a Phase II clinical trial of CPP-1X for the treatment of precancerous gastric lesion patients who are at high gastric cancer risk.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | Gastric (Stomach) Cancer | Gastroenterology | Pharmaceuticals